ResearcherSichuan UniversityActive in the last 2 years

Xi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5398-3854; OpenAlex author ID A5100329833, A5107957444. Sources: OpenAlex.

Their work

Papers: 3 (first author 2, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 3

Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-1304 ↗
Exploring the application and future outlook of Artificial intelligence in pancreatic cancer. First author DOI 10.3389/fonc.2024.1345810 ↗
Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a case report. First author DOI 10.1186/s12883-023-03140-7 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mengying Zhu · 1 shared paper, 2024 · strength 0.28
- Paper Exploring the application and future outlook of Artificial intelligence in pancreatic cancer. DOI 10.3389/fonc.2024.1345810 ↗
Guohua Zhao · 1 shared paper, 2024 · strength 0.28
- Paper Exploring the application and future outlook of Artificial intelligence in pancreatic cancer. DOI 10.3389/fonc.2024.1345810 ↗
Yue Wang · 1 shared paper, 2024 · strength 0.28
- Paper Exploring the application and future outlook of Artificial intelligence in pancreatic cancer. DOI 10.3389/fonc.2024.1345810 ↗
Chanjuan Shi · 1 shared paper, 2025 · strength 0.25
- Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304 ↗
Jason A. Castellanos · 1 shared paper, 2025 · strength 0.25
- Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304 ↗
Nipun B. Merchant · 1 shared paper, 2025 · strength 0.25
- Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304 ↗
Nagaraj S. Nagathihalli · 1 shared paper, 2025 · strength 0.25
- Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304 ↗
Michael Nathan VanSaun · 1 shared paper, 2025 · strength 0.25
- Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304 ↗
Wanrui Lv · 1 shared paper, 2023 · strength 0.24
- Paper Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a c… DOI 10.1186/s12883-023-03140-7 ↗
Ke Cheng · 1 shared paper, 2023 · strength 0.24
- Paper Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a c… DOI 10.1186/s12883-023-03140-7 ↗
Dan Cao · 1 shared paper, 2023 · strength 0.24
- Paper Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a c… DOI 10.1186/s12883-023-03140-7 ↗
Jianping He · 1 shared paper, 2023 · strength 0.24
- Paper Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a c… DOI 10.1186/s12883-023-03140-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.